Stephan Babirak, Ph.D., M.D.
Stephan Babirak, Ph.D., M.D., attended the University of Illinois where he completed his undergraduate degree with honors in 1974 and then completed a Doctorate degree with a PhD in Physiology and Biophysics in 1980. He earned his MD degree in 1983 from the Chicago Medical School. Dr. Babirak completed his Internal Medicine Residency at Mayo Clinic in Rochester, MN, as well as a Fellowship in Metabolism, Endocrinology and Nutrition, at the University of Washington in Seattle. Dr. Babirak is a Fellow of the American College of Physicians, a Fellow of the American Heart Association’s scientific council in Arteriosclerosis and a Fellow in the American College of Endocrinology. Currently, he is Board Certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. In the past, he has been Co-Director of Diabetes Wellness Clinic, Co-Director of the Lipid Clinic and Assistant Chief of Endocrinology at Wilford Hall USAF Medical Center. He also has been the Chief of Endocrinology at Saint VincentHealth Center in Erie, PA and past Director of the Diabetes Division at Maine Medical Center. Dr. Babirak is currently an Associate Professor of Medicine at University of Vermont and Tufts Medical Center. He is President and Medical Director of Metabolic Leader, his private Endocrinology practice, in Scarborough, ME.
Faculty Disclosure: Amgen, Regeneron, (grant research support) Regineron (consultant), Merck, AZ, NovoNordisk, Sanofi, Lilly Eli, Abbvie, Janssen (Speaker’s Bureau). Dr. Babirak’s presentation will include unapproved/ investigative clinical trial data from Victoza and Jardiance. Metabolic Leader, LLC. PA